Deruxtecan-Eribulin

SKU: orb2802118

Description

Deruxtecan-Eribulin is a novel antibody-drug conjugate (ADC) linker-payload, combining the DNA topoisomerase I inhibitor Exatecan and the microtubule inhibitor Eribulin. This dual-mechanism conjugate is a key reagent for constructing ADCs used in cancer research, enabling the evaluation of targeted cytotoxicity in both in vitro and in vivo experimental models.

Research Area

Pharmacology & Drug Discovery

Key Properties

• MW: 2315.54
• Formula: C₁₂₀H₁₄₈FN₁₅O₃₁
• Target: Drug-Linker Conjugates for ADC,Ligands for E3 Ligase

Storage & Handling

• Storage: -20°C
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Quick Database Links

Gene Symbol

Drug-Linker Conjugates for ADC,Ligands for E3 Ligase